Understanding how hormone therapy and radiation work together to reduce brain metastases in breast cancer.
Mechanisms of endocrine therapy and radiation synergism to decrease brain metastases
This study is looking at why young women with breast cancer often face tougher challenges, like aggressive tumors and brain spread, and it’s exploring how certain hormone treatments combined with radiation might help boost the immune system to fight these issues better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10902514 on NIH RePORTER |
What this research studies
This research investigates the reasons why young women with breast cancer are more likely to develop aggressive forms of the disease and brain metastases. It focuses on the role of the hormone estradiol and how endocrine therapies, when combined with radiation therapy, can enhance the immune response against tumors in the brain. By studying the interactions between these treatments and the brain's immune environment, the research aims to improve treatment strategies for young women diagnosed with triple-negative breast cancer. The findings could lead to better management of brain metastases in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are young women diagnosed with breast cancer, especially those with triple-negative breast cancer.
Not a fit: Patients with non-breast cancer-related brain metastases or those who do not have hormone-sensitive tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for young women with breast cancer, particularly those at risk for brain metastases.
How similar studies have performed: Previous research has shown promising results in combining endocrine therapies with radiation for treating various cancers, suggesting potential success for this approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Cittelly, Diana M. — University of Colorado Denver
- Study coordinator: Cittelly, Diana M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.